Sebastian Krammer

Dr. Sebastian Krammer


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2022 in Journal of Biophotonics
Verified
Journal Article
Open access
GVGabriela Vladimirova
Gabriela Vladimirova
CRCristel Ruini
Cristel Ruini
FKFlorian Kapp
Florian Kapp
BKBenjamin Kendziora
Benjamin Kendziora
EEEcem Z. Ergün
Ecem Z. Ergün
DHDaniela Hartmann
Daniela Hartmann
Ex vivo confocal laser scanning microscopy (ex vivo CLSM) is a novel diagnostic tool for a quick bedside evaluation of freshly excised tissue, comparable to histology. We aimed to assess the sensitivity and specificity of ex vivo CLSM in detecting malignant features, to validate its reliability in identifying various skin tumours based on a combination of confocal features and to evaluate the digital staining mode (DS). One‐hundred twenty freshly excised skin samples from 91 patients were evaluated. Each lesion was screened for the presence of 23 predefined confocal criteria with ex vivo CLSM, followed by a histopathological examination. The diagnostic agreement between ex vivo CLSM and histology was 89.2%. The diagnostic accuracy of ex vivo CLSM in detecting malignancy reached a sensitivity of 98% and a specificity of 76%. Ex vivo CLSM enabled a rapid identification of the most common skin tumours, the tumour dignity and cytological features. The DS demonstrated a close resemblance to conventional histopathology.

12 November 2019 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
SKSebastian Krammer
Sebastian Krammer
CKChristian Krammer
Christian Krammer
SSSuzanna Salzer
Suzanna Salzer
IBIşin Sinem Bağci
Işin Sinem Bağci
LFLars E. French
Lars E. French
Daniela HartmannDaniela Hartmann
Daniela Hartmann
For many types of cancer, immune checkpoint inhibitors have proven to be a highly effective treatment. The monoclonal anti-PD-1 antibody nivolumab stimulates the immune system and is one of the newest treatment options for non-small cell lung cancer. In doing so, immune checkpoint inhibitors can trigger many skin lesions that have not yet been completely investigated in their entirety. In this case report, pemphigus vulgaris is identified as a potential adverse event that occurs under the treatment with nivolumab. In addition to the standard methods, we examined our patient's samples with ex vivo confocal laser scanning microscopy. This is a new and innovative diagnostic method that uses vertical scanning to provide fast, high-resolution imaging of freshly excised tissue, even using fluorescently labeled antibodies.

6 October 2020 in Journal of Biophotonics
Verified
Journal Article
Closed access
PDF file
IBIşın Sinem Bağcı
Işın Sinem Bağcı
RARui Aoki
Rui Aoki
SKSebastian Krammer
Sebastian Krammer
GVGabriela Vladimirova
Gabriela Vladimirova
TRThomas Ruzicka
Thomas Ruzicka
Daniela HartmannDaniela Hartmann
Daniela Hartmann

17 May 2022 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Open access
TWT. Willem
T. Willem
SKSebastian Krammer
Sebastian Krammer
ABA.‐S. Böhm
A.‐S. Böhm
LFL.E. French
L.E. French
Daniela HartmannDaniela Hartmann
Daniela Hartmann
ABA. Buyx
A. Buyx
Background Visual data are particularly amenable for machine learning techniques. With clinical photography established for skin surveillance and documentation purposes as well as progress checks, dermatology is an ideal field for the development and application of emerging machine learning health care applications (ML-HCAs). To date, several ML-HCAs have detected malignant skin lesions on par with experts or found overlooked visual patterns that correlate with certain dermatological diseases. However, it is well established that ML-HCAs come with ethical and social implications. Objectives Currently, there is a lack of research that establishes model design, training, usage and regulation of such technologies sufficient to ensure ethically and socially responsible development and clinical translation, specifically within the field of dermatology. With this paper, we aim to give an overview of currently discussed ethical issues relating to dermatological ML-HCAs. Methods On the basis of a thematic, keyword-based literature search, we performed an ethical analysis against established frameworks of biomedical ethics. We combined our results with current, relevant normative machine learning ethics literature to identify the status quo of the ethics of ML-HCAs in dermatology. We describe the benefits and risks of dermatological ML-HCAs that are currently being developed for clinical purposes. Results The potential benefits range from better patient outcomes to better knowledge accessibility to decreasing health care disparities, that is, standards of care between different population groups. The risks associated with ML-HCAs range from confidentiality issues to individual patient outcomes as well as the exacerbation of prevalent health care disparities. We discuss the practical implications for all stages of dermatological ML-HCA development. Conclusion We found that ML-HCAs present stakeholder-specific risks for patients, health care professionals and society, which need to be considered separately. The discipline lacks sufficient biomedical ethics research that could standardize the approach to ML-HCA model design, training, use and regulation of such technologies.

10 August 2022 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Open access
SKSebastian Krammer
Sebastian Krammer
YLY. Li
Y. Li
NJN. Jakob
N. Jakob
ABA.S. Boehm
A.S. Boehm
HWH. Wolff
H. Wolff
Daniela HartmannDaniela Hartmann
Daniela Hartmann
Background: Artificial intelligence (AI) techniques are promising in early diagnosis of skin diseases. However, a precondition for their success is the access to large‐scaled annotated data. Until now, obtaining this data has only been feasible with very high personnel and financial resources.Objectives: The aim of this study was to overcome the obstacle caused by the scarcity of labelled data.Methods: To simulate the scenario of label shortage, we discarded a proportion of labels of the training set. The training set consisted of both labelled and unlabelled images. We then leveraged a self‐supervised learning technique to pretrain the AI model on the unlabelled images. Next, we fine‐tuned the pretrained model on the labelled images.Results: When the images in the training dataset were fully labelled, the self‐supervised pretrained model achieved 95.7% of accuracy, 91.7% of precision and 90.7% of sensitivity. When only 10% of the data were labelled, the model could still yield 87.7% of accuracy, 81.7% of precision and 68.6% of sensitivity. In addition, we also empirically verified that the AI model and dermatologists are consistent in visually inspecting the skin images.Conclusions: The experimental results demonstrate the great potential of the self‐supervised learning in alleviating the scarcity of annotated data.

6 November 2020 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
SKSebastian Krammer
Sebastian Krammer
CKChristian Krammer
Christian Krammer
GVGabriela Vladimirova
Gabriela Vladimirova
SSSuzanna Salzer
Suzanna Salzer
CRCristel Ruini
Cristel Ruini
Daniela HartmannDaniela Hartmann
Daniela Hartmann
Ex vivo confocal laser scanning microscopy (CLSM) is an innovative imaging tool that enables real-time examination of specimens and may be used in evaluating fungal infections. We aimed to assess the applicability of ex vivo CLSM in the diagnosis of onychomycosis by comparing results to those obtained by histopathology, potassium hydroxide (KOH) examination, and fungal culture. In this prospective study, 57 patients with the clinical diagnosis of distal nail fungal infection were examined and compared using all four of the above-mentioned diagnostic tools in terms of sensitivity, positive and negative predictive value. Ex vivo CLSM showed the highest sensitivity, followed by KOH examination, histopathology and fungal culture. Regarding positive and negative predictive values, ex vivo CLSM was superior and showed even higher sensitivity than the combined gold standard comprised of KOH examination, fungal culture or histopathology.